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Amphibian skin secretions are an important treasure house of bioactive antimicrobial
peptides (AMPs). Despite having been the focus of decades of research in this
context, investigations of phyllomedusine frogs continue to identify new AMPs
from their skin secretions. In this study, the prototype of a novel family of AMP
distinctin-like-peptide-PH (DLP-PH) was identified from the skin secretion of the
otherwise well-studied Tiger-Legged Tree Frog Phyllomedusa hypochondrialis through
cloning of its precursor-encoding cDNA from a skin secretion-derived cDNA library by a
3′-rapid amplification of cDNA ends (RACE) strategy. Subsequently, the mature peptide
was isolated and characterized using reverse-phase HPLC and MS/MS fragmentation
sequencing. DLP-PH adopted an α-helical conformation in membrane mimetic solution
and demonstrated unique structural features with two distinct domains that differed
markedly in their physiochemical properties. Chemically synthesized replicates of
DLP-PH showed antimicrobial activity against planktonic bacterial and yeast cells, but
more potent against Escherichia coli at 32µg/mL. However, DLP-PH showed much
weaker inhibitory activity against the growth of sessile cells in biofilms. In addition,
DLP-PH exhibited anti-proliferative activity against human cancer cell lines, H157, and
PC3, but with no major toxicity against normal human cell, HMEC-1. These combined
properties make DLP-PH deserving further study as an antimicrobial agent and further
investigations of its structure-activity relationship could provide valuable new insights into
drug lead candidates for antimicrobial and/or anti-cancer purposes.
Keywords: frog skin secretion, molecular cloning, antimicrobial peptide, distinctin, anti-biofilm, anti-proliferation
INTRODUCTION
Not even a century after the discovery of penicillin marked a new era is the treatment of
bacterial infectious agents, modern medicine is quickly reaching a crossroads with respect to
the utility of antibiotics in health care. Two trends are especially apparent and worrisome in
what is an evolutionary arms race. The first is the recent, rapid increase in the emergence
of drug-resistant infectious agents (“superbugs”) caused, in part, through the inappropriate
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prescribing of conventional antibiotics (Poole, 2011). The second
is the natural ability of diverse bacterial species to form
biofilms. These biofilms, which are derived from the hydrated
polymeric matrices of sessile bacterial cells, are potently resistant
to conventional treatment because of their thick, slimy, and
slippery coating and can thus cause persistent, serious infections.
Progressive evidences on biofilms represent a natural defensive
strategy on the part of the bacteria, in response to sub-inhibitory
antibiotic doses (Karatan and Watnick, 2009). Whereas, recent
efforts have been directed to some extent at modifying existing
antibiotics to increase their potency (e.g., vancomycin; Okano
et al., 2017), a useful alternative strategy might be the discovery
and application of novel antibiotic compounds with a different
mode of action to conventional antibiotics.
In this second context, antimicrobial peptides (AMPs) have
attracted the attention of many researchers because of their
numerous unique advantages, such as potent effects against a
variety of pathogens, including many superbugs, their ability to
suppress biofilm formation (Reffuveille et al., 2014; Pletzer and
Hancock, 2016), and that their apparent primary mechanism of
action (degradation of the microbial membrane) might prove to
be more resistant to the development of antibiotic resistance.
Moreover, in addition to their direct antimicrobial activities,
AMPs have been recently discovered to possess beneficial,
secondary actions such as mediating the immune response and
enhancing both wound healing and angiogenesis (Samy et al.,
2011; Habets and Brockhurst, 2012).
An important natural resource for AMPs, are the skin
secretions of amphibians, which, in addition to AMPs, also
contain a cocktail of other chemically complex bioactive
molecules displaying a wide range of activities. Indeed,
amphibians AMPs have attracted much attention over the past
decades (Xu and Lai, 2015), with over one-third of the nearly
3000 naturally occurring AMPs listed in the Antimicrobial
Peptide Database (http://aps.unmc.edu/AP) coming from
amphibians and 90% of those from frogs and toads. Nevertheless,
the potential of amphibian skin secretions as a source of AMPs
and of the AMPs themselves as a source of novel antibiotics has
barely been tapped. Many new amphibian AMPs remain to be
discovered and the AMPs that are already known either possess
potent antimicrobial activities that deserve further study or can
be used as templates for computer-aided drug design to enhance
their efficacy.
Within this latter context, we describe a novel AMP precursor
that we identified from the skin secretion of Phyllomedusa
hypochondrialis. The mature peptide, which we called distinctin-
like-peptide-PH (DLP-PH), displayed a number of interesting
characteristics deserving further investigation, including an
evaluation of its bioactivities.
METHODS
Secretion Acquisition and Maintenance of
Experimental Specimens
Four adult specimens of P. hypochondrialis were obtained from a
commercial source in Peru (PeruBiotech E.I.R.L., Lima, Santiago
de Surco, Peru). The frogs were housed in a tropical frog vivarium
at 25◦C and 85% humidity under a 12 h/12 h day/night cycle and
were fed multivitamin-loaded crickets three times per week. The
skin secretions were sampled via the minimally invasive method
of mild transdermal electrical stimulation (Tyler et al., 1992) after
the frogs had been raised for 4 months under these conditions.
For this study, all frogs have been raised for 23 months. The
secretions were then washed into an ice-chilled glass beaker
using distilled deionized water and lyophilised. In total, 29.7mg
of dry skin secretion were harvested. Secretion acquisition
was performed under UK Animal (Scientific Procedures) Act
1986, project license PPL 2694 as issued by the Department of
Health, Social Services and Public Safety, Northern Ireland. All
procedures were vetted by the IACUC of Queen’s University
Belfast and approved on March 1, 2011.
Construction of a Skin Secretion-Derived
cDNA Library and “Shotgun” Cloning
Five milligrams of lyophilised P. hypochondrialis skin secretion
were dissolved in 1mL of cell lysis/mRNA binding buffer
supplied in a Dynabeads Kit (Dynal Biotech, Merseyside,
UK). The polyadenylated mRNA was isolated by using
the magnetic oligo-dT beads in accordance with the
manufacturer’s instructions. The isolated mRNAs were
then reverse-transcribed to construct a cDNA library using
a SMART-RACE Kit (Clontech, Palo Alto, CA, USA) and
the 3’-RACE reactions to acquire full-length prepropeptide
nucleic acid sequence data. Potential AMPs were then amplified
from this library through the combination of the nested
universal primer (5′-AAGCAGTGGTATCAACGCAGAGT−3′)
that was supplied with the kit with a degenerate primer
(5′-ACTTTCYGAWTTRYAAGMCCAAABATG-3′) that
we designed to bind to a highly-conserved segment of the
5′-untranslated region of bioactive peptide cDNAs from
phyllomedusine frogs (Wechselberger et al., 1998; Pierre et al.,
2000). The RACE products were purified using a Cycle-Pure
Kit (Omega Bio-Tek, Norcross, GA, USA) and cloned into
a pGEM-T vector (Promega Corporation, Southampton,
UK). Sequencing reactions were performed using a BigDye
Terminator Sequencing Kit (Applied Biosystems, Foster City,
CA, USA) in combination with an ABI 3100 automated capillary
sequencer (Applied Biosystems, Foster City, CA, USA).
Identification and Primary Structure
Analysis of Mature Peptide in Crude Skin
Secretion
Another five milligrams of the lyophiled skin secretion of
P. hypochondrialis were dissolved in 0.5mL of 0.05/99/95
(v/v) trifluoroacetic acid (TFA)/water and centrifuged for
clarification. The supernatant was then analyzed using a
gradient RP-HPLC system (Waters, Milford, MA, USA) fitted
with an analytical column (Aeris PEPTIDE XB, C18, 5µm,
10.0 × 250mm, Phenomenex, Macclesfield, Cheshire, UK).
Contents were eluted from the column using a linear gradient
composed of 0.05/99.95 (v/v) TFA/water to 0.05/19.95/80.00
(v/v/v) TFA/water/acetonitrile over 240min at a flow rate of
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1 mL/min. The eﬄuents were collected at 1-min intervals
and their UV absorbance were monitored at both 214 and
280 nm simultaneously. Samples from each fraction were
subsequently analyzed by MALDI-TOF MS (Voyager DE,
PerSeptive Biosystems, Foster City, CA, USA) using α-cyano-4-
hydroxycinnamic acid as the matrix. The fraction that contained
a peptide with a molecular mass coincident with the mass of
the mature peptide deduced from the cloned precursor-encoding
cDNA was infused onto an LCQ-Fleet ion-trap MS (Thermo
Fisher Scientific, San Francisco, CA, USA) for fragmentation
sequencing.
Solid-Phase Peptide Synthesis
Following the unequivocal confirmation of the primary structure
of the mature peptide in the preceding step, the native peptide as
well as three truncated versions of it (the N-terminal domain, the
C-terminal domain, and a slightly extended version of the latter)
were chemically synthesized via solid-phase Fmoc chemistry
using a Tribute automated synthesizer (Protein Technologies,
USA). Corresponding Wang-resins, protected amino acids, N-
methylmorpholine (NMM), piperidine, 2-(1H-benzotriazol-1-
yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU),
N,N-dimethylformamide (DMF), and dichloromethane (DCM)
were used during the synthesis. The TFA/triisopropylsilane
(TIPS)/water cocktail was used to cleave the peptide from
the resin and to deprotect the side-chains. All peptides were
analyzed and purified using RP-HPLC. Both molecular masses
from MALDI-TOF and MS/MS fragmentation profiles were
also employed to determine the purity and authenticity of the
respective structures.
Determination and Visualization of Peptide
Secondary Structures
In the first instance, secondary structures of the synthesized
peptides were determined via circular dichroism (CD) using a
JASCO J-815CD spectrometer (Jasco, Essex, UK). The peptides
were dissolved initially in 10mM ammonium acetate and 50%
TFE in 10mM ammonium acetate to reach a concentration of
100µM and then added into a 1-mm high-precision quartz cell
(Hellma Analytics, Essex, UK). CD spectra were obtained at 20◦C
from 190 to 250 nm at a scanning speed of 100 nm/min with 1 nm
bandwidth and 0.5 nm data pitch.
Additionally, we used several modeling methods to further
elucidate secondary structures as well as to investigate possible
mechanisms of action of the peptides. Helical Wheel Projection
(http://rzlab.ucr.edu/scripts/wheel/wheel.cgi) was used to
visualize the α-helical peptide and the I-TASSER online server
(Yang et al., 2015) was employed to predict the secondary
structures of the native peptide and its derivatives and to infer
their 3-D structural models. The overall quality of these models
were quantified by Ramachandran plots using RAMPAGE
(Lovell et al., 2003) and by z-scores using ProSA (Wiederstein
and Sippl, 2007). The physiochemical parameters of the AMPs
were predicted using HeliQuest (Gautier et al., 2008).
As DLP-PHwasmore effective against the growth of E. coli, we
aimed to simulate the antimicrobial mechanism using the E. coli
membrane model (Pandit and Klauda, 2012), which has been fit
to experimentally determined results and consists of six different
lipids, was reconstructed through CHARMM-GUI (Jo et al.,
2008). We then adopted the water-removed model to simulate
AMP-membrane interaction. Molecular docking was performed
using AutoDock Tools and AutoDock Vina (Trott and Olson,
2010). The aforementioned water-removed membrane model
was used as the receptor molecule, the absent polar hydrogens
were added to this molecule through AutoDock Tools and then
saved as a formatted pdbqt file. The grid box was set to cover the
outer leaflet with the center in 0, 0, 14 (x, y, z); and its size was set
to 69 for each of the three axes, the optimal box size 69 for DLP-
PH as determined by the eBoxSize script (Feinstein and Brylinski,
2015). The DLP-PH model file was input to AutoDock Tools
as the ligand molecule. The Gasteiger charges were added and
the non-polar hydrogens were merged automatically. Then the
missing polar hydrogens were added, the chemical bonds torsions
were adjusted and the molecule was output to a pdbqt formatted
file. Exhaustiveness was set to 20 given that the volume of the
search space was larger than 27000 Å3. All the information was
written into a configuration file and was calculated by AutoDock
Vina. The calculated molecular docking result with the best
affinity score was rendered with the PyMol (PyMOL Molecular
Graphics System, Version 1.8 Schrödinger, LLC).
Antimicrobial Susceptibility Assays
The antimicrobial activities of the synthetic peptides were
assayed against both planktonic microbial cells as well as
sessile cells in biofilms. In the former case, we quantified
both the minimal inhibitory (MIC) and minimal bactericidal
concentrations (MBC) against planktonic cells of the gram-
positive bacterium Staphylococcus aureus (NCTC 10788), the
gram-negative bacteria Escherichia coli (NCTC 10418) and
Pseudomonas aeruginosa (ATCC 27853), and the yeast Candida
albicans (NCYC 1467) using the micro broth dilution method
(Gao et al., 2016; Wu et al., 2016). The peptides were dissolved in
physiological phosphate buffered saline (PBS) to prepare a series
of 100-fold stock solutions via 2-fold dilutions, where 2 µL of
each peptide solution wasmixed with 198µL of dilutedmicrobial
culture to achieve a range of final concentrations from 512 to
1µg/mL. Similarly, a divalent cation supplemented medium (20
mg/L Mg2+ and 10 mg/L Ca2+) was also used to determine
the MICs in the presence of cations. For all assays, MICs were
defined as the lowest concentration of peptides that resulted in
the absorbance less than 0.1 in the 96-well plates whereas MBCs
were defined as the lowest concentration that showed no colony
growth on MHA plates.
Susceptibility assays against sessile cells in biofilms were
conducted by quantifying theminimal biofilm inhibition (MBIC)
and the minimal biofilm eradication concentrations (MBEC) as
well as the biofilm initial attachment inhibition against all the
strains. MBIC and MBEC testing was performed, with minor
modifications, according to Knezevic and Petrovic (2008) and
Sabaeifard et al. (2014), using the colourimetric indicator 2,3,5,-
triphenyl tetrazolium chloride (TTC) to estimate microbial cell
viabilities. C. albicans was cultured in RPMI-1640 and the other
strains were cultured in MHB with 2% glucose, respectively.
Overnight cultures were washed once with pre-warmed PBS and
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diluted with fresh medium to 107 CFU/mL. For the MBIC assay,
the peptide stock solutions were prepared in the same way with
the same concentration range as for the MIC assays and then
incubated at 37◦C for 24 h. Thereafter, the plates were washed
twice with PBS followed by the addition of 200 µL fresh MHB
with 2% glucose (or RPMI-1640 for C. albicans) and 50 µl 1%
TTC (g/v) solution per well. After 5 h incubation, 200 µL of the
supernatant from each well were transferred to a new plate and
its absorbance at 470 nm was determined using a Synergy HT
plate reader (BioTek, Winooski, VT, USA). For the MBEC assay,
200 µL of the same diluted inoculum was dispersed into each
well in a flat-bottomed 96-well plate for 48 h to form mature
biofilms. Following sufficient time, the plates were washed three
times with PBS to remove the planktonic cells and incubated
with the same concentration range of peptide solutions as above
at 37◦C for 24 h. Thereafter, each well was washed, refilled
with fresh medium, stained with TTC, and incubated for a
further 5 h. Absorbance was measured in the same way as with
the MBIC assays. MBICs and MBECs were determined as the
lowest concentrations at which no colourimetric metabolites
were formed by the bacteria.
The biofilm initial attachment (IA) inhibition assay was
performed using P. aeruginosa, a strong biofilm-producing
bacterium, using a slightly modified version of the method
of Zhang et al. (2016). Briefly, different concentrations of the
peptide solutions and diluted bacterial inoculum were loaded in
the same way as with the MBIC assays, but with an incubation
time of only 1 h and also without agitation to facilitate bacterial
binding. Thereafter, the wells were washed with PBS, fixed
with methanol, air-dried and stained with 0.1% (w/v) crystal
violet, and washed with tap water before being air-dried. Finally,
the crystal violet was solubilized in 33% acetic acid and the
absorbance at 550 nm was measured in a plate reader to calculate
the IC50 of biofilm initial attachment inhibition.
Cytoplasmic Materials Leakage Assay
As an indicator of the potential lysis of the microbial cell
membranes in the presence of the peptides, we performed a
cytoplasmic material leakage assay (Sahu et al., 2009; Samanta
et al., 2013). Briefly, overnight microbial cultures of S. aureus,
E. coli, and C. albicans were washed with pre-warmed PBS and
diluted to 5 × 105 CFU/mL in PBS. The synthesized peptides to
be tested were dissolved in PBS and 2-fold diluted as described
above to achieve a final concentration range from 512 to 1µg/mL.
Triton-X 100 (0.2%) in PBS was used as a positive control, with
100 µL of different concentrations of the peptide in PBS (512 to
1µg/mL) being used as blank controls. The plates were incubated
at 37◦C for 2 h before the contents in each well were filtered
through 0.22-µm syringe filters (Sigma-Aldrich, St. Louis, MO,
USA) into new plates. A volume of 100 µL of the supernatant
was transferred into a new 96-well plate and the absorbance at
260 nm was measured using a plate reader.
Haemolysis Assay
We examined for potential hemolytic activity of DLP-PH and
its derivatives using a 4% suspension of horse red blood
cells (TCS Biosciences, Botolph Claydon, Buckingham, UK)
in physiological PBS. Each peptide was tested within the
concentration range of 1 to 512µg/mL (see above), with each
peptide concentration being incubated with the red blood cell
suspension at 37◦C for 2 h. PBS solution and an equal volume of
PBS solution containing 2% of Triton X-100 (Sigma-Aldrich, St.
Louis, MO, USA), a non-ionic detergent, were used as negative
and positive controls, respectively. After 2 h, each peptide-cell
mixture was centrifuged and 200 µL of supernatant were added
to each well of a 96-well microtiter plate. The degree of lysis of
the red blood cells was assessed by measuring the absorbance at
550 nm using a microplate reader.
Assessment of Anti-proliferation Effect and
Cytotoxicity on Human Cancer and Normal
Cell Lines
Possible anti-cancer activities of the novel peptide were
investigated against a range of five human cancer cells lines:
human prostate carcinoma cell line PC-3 (ATCC-CRL-1435) and
human non-small cell lung cancer cell line H-157 (ATCC-CRL-
5802) were cultured in RPMI-1640 medium (Gibco, Invitrogen,
Paisley, UK) with 10% fetal bovine serum (FBS) (Sigma-Aldrich,
St. Louis, MO, USA) and 1% Penicillin-Streptomycin (PS)
(Invitrogen, Paisley, UK), whereas human breast melanoma
cell line MDA-MB-435s (ATCC-HTB-129), human breast
adenocarcinoma cell line MCF-7 (ATCC-HTB-22), and human
neuronal glioblastoma cell line U251MG (ECACC-09063001)
were cultured in DMEM medium (Invitrogen, Paisley, UK) with
10% FBS and 1% PS. As a control, humanmicrovessel endothelial
cell line HMEC-1 (ATCC-CRL-3243), which was cultured in
10% FBS, 10 ng/mL epidermal growth factor (EGF) (Invitrogen,
Paisley, UK), 10mM L-glutamine (Invitrogen, Paisley, UK) and
1% PS loaded MCDB131 medium (Invitrogen, Paisley, UK), was
used to evaluate the cytotoxicity of the synthetic peptides on
normal human cell line.
Cell antiproliferative activity was assessed using the MTT cell
viability assay. Briefly, the cells were counted and seeded in 96-
well plates at a density of 5000 cells per well for 24 h. Thereafter,
the cells were synchronized by treating them with serum-free
medium for a further 12 h after which they were incubated for
24 h with the peptide dissolved in serum-free medium over a
concentration range of 419.7 to 4.197 × 10−3 µg/mL. After the
incubation period, 10 µL of 5 mg/mL MTT solution (Sigma-
Aldrich, St. Louis, MO, USA) were added to each well and
incubated for a further 4 h. All cells were cultured in an incubator
with a humidified environment with 5%CO2 at 37◦C. Finally, the
supernatant in each well was removed and replaced with 100 µL
dimethylsulfoxide (DMSO) and the absorbance of each well at
570 nm being determined using a plate reader.
Cell cytotoxicity activity was assessed using the LDH assay
(Pierce LDH cytotoxicity assay kit, Thermo Scientific), and the
experiment followed the instruction provided with the kit. The
cells were seeded in a 96-well plate as described above and
synchronized for a further 4 h. Afterwards, the cells were treated
with the same concentration range of DLP-PH as used in the
MTT assay and incubated for 45min. Lysis solution and ddH2O
were applied as positive and negative control, respectively. After
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incubation, 50 µL of each sample medium were transferred into
another 96-well plate and mixed with 50 µL of LDH reaction
mixture. Each sample was further mixed with 50 µL of stop
solution after a 30min incubation period with the absence of
light at room temperature. The LDH activity was measured by
the absorbance at 490 nm, which subtracted the absorbance at
680 nm.
Statistical Analyses
For all assays, all peptide concentrations and controls were
tested in three independent experiments of five replicates each.
The statistical analyses employed t-test and one-way ANOVAs,
with the statistical significance of the differences being indicated
as ∗(p < 0.05), ∗∗(p < 0.01), and ∗∗∗(p < 0.001). The dose-
response curves were constructed using a “best-fit” algorithm and
HC50 and IC50 values were calculated through the data-analysis
package in GraphPad Prism 6 (GraphPad Software, La Jolla, CA,
USA).
RESULTS
Identification and Characterization of a
DLP-PH Precursor cDNA From a Skin
Secretion-Derived cDNA Library
Through shotgun cloning of the P. hypochondrialis skin secretion
derived cDNA library, we consistently retrieved a cDNA
encoding the precursor of a novel peptide (DLP-PH) with an
open reading frame of 80 amino-acid residues, including a signal
peptide terminating in a cysteine residue; an acidic amino-acid
residue-rich spacer peptide; and a predicted putative mature
peptide of 36 amino-acid residues. The predicted mature peptide
appeared after a lysine-arginine (KR) motif, which is a typical
propeptide convertase cleavage processing site (Figure 1A). The
nucleotide sequence of the entire cDNA encoding DLP-PH
has been deposited in the EMBL sequence database under
the accession number LT718215. An NCBI BLAST analysis,
showed that the DLP-PH precursor exhibited a high degree of
structural identity with another distinctin-like peptide precursor
from Phyllomedusa azurea, including an identical mature peptide
region and highly-conserved signal/spacer peptide regions
(Accession No.: Q17UZ0). Additionally, the DLP-PH peptide
precursor demonstrated strong similarity to the B-chain peptide
(distinctin-B) precursor of the heterodimeric AMP distinctin
from Phyllomedusa distincta (Batista et al., 2001; Evaristo et al.,
2013) along most of the entire precursor-encoding cDNA of
the latter. Noticeable dissimilarity only arose in the C-terminal
domain of the mature peptides, with DLP-PH also being much
longer than distinctin-B (Figures 1B,C).
MALDI-TOF mass spectrometry analyses of the fractionated
skin-secretion samples from RP-HPLC (Figure S1A) identified
a peptide coincident in molecular mass to that of the mature
peptide predicted from the cloned cDNA (4196.9) in fraction
#118. MS/MS fragmentation sequencing of a sample of this
fraction (Figure S1B) confirmed the primary structure of the
mature peptide.
Prediction of Secondary Structure and
Physiochemical Properties
The z-score of −1.34 for the 3D model of DLP-PH predicted
using I-TASSER is within the range of scores typically found for
protein/peptide native folds identified by NMR with similar size
(Figure S2A). Moreover, assessment of stereo-chemical backbone
of the DLP-PH model via the Phi and Psi dihedral angles of
the Ramachandran plot showed that all residues were in the
favored regions (Figure S2B). Themodel revealed that the peptide
should adopt an α-helical conformation, which was verified by
CD assays. Whereas, the mature peptide existed as a random
coil in aqueous solution, it did indeed form a typical α-helical
structure with negative bands at 208, 222 nm and a positive band
at 190 nm in the membrane-mimetic TFE solution (Figure S2C).
FIGURE 1 | The biosynthetic precursor of DLP-PH and the comparison with Distinctin-B. (A) Nucleotide and translated open-reading frame amino acid sequence of a
cDNA encoding the DLP-PH precursor cloned from a P. hypochondrialis skin secretion library. The predicted mature peptide is single underlined, the signal peptide is
double-underlined and the stop codon is indicated by an asterisk. (B) The alignment of amino acid sequences of distinctin-B and DLP-PH precursors. (C) The
alignment of corresponding precursor-encoding cDNA sequences. Conserved residues/bases are indicated in red with a yellow highlight. Similar residues are
highlighted in green.
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The best molecular docking model between DLP-PH and
the model of the E. coli cytoplasmic membrane showed a
binding affinity of −3.5 kcal/mol, with DLP-PH bonding to
the hydrophilic heads of the phospholipid molecules. Parallel
to this, most of the cationic charged residues (Lys and Arg)
of DLP-PH were predicted to face the cell membrane through
electrostatic attraction (Figure 2A). Both the binding model and
the DLP-PH helical wheel projection plot of DLP-PH (Figure 2B)
indicated that the N-terminal (inner circle in Figure 2B) and C-
terminal domains of the mature peptide (outer circle) possess
distinctly different physiochemical properties, with the former
being amphipathic and the latter hydrophilic. We confirmed
this by synthesizing two additional peptides corresponding to
the two domains of the full peptide (DLP-PHn and DLP-
PHc, respectively) (Table 1). Thus, whereas the entire peptide is
hydrophilic (H = −0.031) and cationic (+8) nature because of
the high proportion of polar residues, DLP-PHn is amphipathic
(µH = 0.487) with a high hydrophobicity (H = 0.358) and
an outstanding hydrophobic face (-YAVGLLLL-) and DLP-PHc
with its comparative lack of non-polar residues shows poor
hydrophobicity (H=−0.480) and amphipathicity (µH= 0.158)
(Table 2). A third peptide, DLP-PHt, was designed by truncating
the native peptide at Asn15 according to that portion of DLP-
PH that shows distinctly reduced homology with the B-chain of
distinctin (Lys14 to Asn36) while avoiding Lys14, which might
be enzymatically sensitive. Compared with DLP-PHc, DLP-
PHt displayed a higher hydrophobicity (H = −0.283) and
amphipathicity (µH = 0.270), but with values that were still
distinctly lower than those for DLP-PH and DLP-PHn.
Antimicrobial Activities
The naturally occurring peptide DLP-PH exhibited activity
against planktonic cells of all four tested microorganisms, albeit
with noticeably less potency against the gram-positive bacterium
S. aureus or in the presence of divalent cations (Table 3). Most of
this activity appears to derive from the N-terminal domain of the
peptide, with DLP-PHc and DLP-PHt being devoid of effective
antimicrobial effects. Only DLP-PHn showed any noteworthy
efficacy, which was at least 2-foldmore effective than that of DLP-
PH in the case of S. aureus. [However, because the molecular
mass of DLP-PHn (2059 Da) is nearly half of that of DLP-
PH (4197 Da), their MICs against S. aureus were quite similar
when viewed in terms of molarity: 62.2 vs. 61.0µM, respectively].
The efficacy of DLP-PH against sessile cells of all strains in
biofilm was strongly reduced compared to the analogous values
against planktonic cells (4- and 8-fold reduced, respectively;
Table 4). The inhibition of biofilm initial attachment (IA) against
P. aeruginosa showed an IA-IC50 value of 96µg/mL (22.8µM)
(Figure 3B).
The cytoplasmic materials release experiment revealed that
DLP-PH lysed nearly 100% of the microbial cells at high
concentrations of peptide (512µg/mL; Figure 3A). Effects at
lower concentrations were organism-specific. Thus, whereas
strong cell lysis was also observed at the MIC of DLP-PH against
S. aureus (256µg/mL), barely any cells of E. coli were lysed at its
MIC of 32µg/mL. By contrast, DLP-PH continued to result in
>50% cell lysis of C. albicans even at concentrations well-below
its MIC (64µg/mL) against this organism.
Bioactivity of DLP-PH on Mammalian Cells
Only DLP-PH and DLP-PHn showed any haemolytic activity
against horse blood red cells, but 100% haemolysis was never
observed even at the highest tested concentration of 512µg/mL.
TABLE 1 | Sequences of DLP-PH, its derivatives, distinctin, and distinctin-B.
Peptide Sequence
DLP-PH NLVSALIEGRKYLKNVLKKLNRLKEKNKAKNSKENN
DLP-PHn NLVSALIEGRKYLKNVLK
DLP-PHc KLNRLKEKNKAKNSKENN
DLP-PHt NVLKKLNRLKEKNKAKNSKENN
Distinctin-B NLVSGLIEARKYLEQLHRKLKNCKV
Distinctin ENREVPPGFTALIKTLRKCKII (A) | NLVSGLIEARKYLEQLHRKLKNCKV (B)
FIGURE 2 | The molecular modeling of DLP-PH structures. (A) Theoretical docking study of DLP-PH with E. coli model membrane. The secondary structure of
DLP-PH is showing in green cartoon, the main chain is hided and side chains are representing in sticks with different colors (designated in the figure according to the
properties of the residues). The phospholipids are presenting in lines with carbon atoms in cyan, oxygen atoms in red, nitrogen atoms in blue, and phosphorus atoms
in orange. (B) Helical wheel projection of DLP-PH with the N-terminal domain in the inner circle and the C-terminal domain in the outer circle.
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TABLE 2 | Physiochemical properties of DLP-PH and its derivatives.
Region Hydrophobicity <H> Hydrophobic moment < µH> Polar residues and G <n> Non-polar residues <n> Net charge <z>
DLP-PH −0.031 0.313 24 12 +8
DLP-PHn 0.358 0.487 9 9 +3
DLP-PHc −0.420 0.158 15 3 +5
DLP-PHt −0.283 0.270 17 5 +6
TABLE 3 | Antimicrobial activity of DLP-PH and its derivatives against planktonic
cells of four reference microorganisms.
S. aureus E. coli P. aeruginosa C. albicans
MIC MBC MIC MBC MIC MBC MIC MBC
DLP-PH 256 512 32(128) 32 64(>512) 128 64 64
DLP-PHn 128 128 128 128 >512 >512 64 64
DLP-PHc >512 >512 >512 >512 >512 >512 512 >512
DLP-PHt 512 >512 >512 >512 >512 >512 256 256
Unit: µg/mL; values in brackets were the MICs tested in divalent cation supplemented
medium.
The remaining designed peptides, DLP-PHc and DLP-PHt,
showed no haemolytic activity whatsoever, thereby mirroring
their weak antimicrobial activities (Figure 3C).
Of the five different cancer cell lines used to screen the anti-
proliferation activity of DLP-PH, evident activity (defined as a
growth inhibition concentration ≥4.197µM) was only shown
against the two cell lines H-157 and PC-3, with IC50 values
15.41 and 32.25µg/mL, respectively (Figure 4A). By contrast,
DLP-PH showed significant cytotoxicity against the normal
human cell line HMEC-1 only at the highest concentration
tested (419.7µg/mL), with the IC50 of 287.2µg/mL also being
much higher than the corresponding values for the two cancer
lines above (Figure 4A). The LDH assay confirmed that DLP-
PH resulted in low degree of cytotoxicity on mammalian cells,
especially HMEC-1, while it exhibited more toxic effect on cancer
cell lines (Figure 4B).
DISCUSSION
Phyllomedusa hypochondrialis represents a well-studied frog
species with respect to its skin secretions, with the Antimicrobial
Peptide Database listing at least 36 AMPs that have been isolated
from this species. Our study identified another novel AMP
for the species, with the mature peptide, DLP-PH, First, as
the name suggests, showing high identity to the 25-residue B-
chain of the AMP distinctin from Phyllomedusa distincta (Batista
et al., 2001), which itself is unusual among AMPs because of
its heterodimeric structure. Furthermore, DLP-PH possessed an
intriguing structure consisting of an N-terminal amphiphilic
region and a C-terminal hydrophilic region. Altogether, these
unique characteristics of DLP-PH argue for it representing the
prototype of a novel AMP family. Compared to the majority of
amphibian AMPs, DLP-PH is unusual because of the extremely
heterogeneous properties of its N- and C-terminal domains,
TABLE 4 | Anti-biofilm activity of DLP-PH against all tested microorganisms.
Microorganisms MBIC MBEC
S. aureus >512 (>122.0) >512 (>122.0)
E. coli 128 (30.5) 256 (61.0)
P. aeruginosa 512 (122.0) 512 (122.0)
C. albicans 256 (61.0) 512 (122.0)
µg/mL, molarity was calculated and shown in the brackets.
with only the former displaying the characteristics typical of
amphibian AMPs (i.e., high amphiphilicity and hydrophobicity)
and thus seemingly contributing most to the antimicrobial
activity of the entire peptide. By contrast, the C-terminal end
was hydrophilic, less amphiphilic and, as evidenced by the DLP-
PHc peptide that we designed, devoid of any antimicrobial
activity on its own. However, some possible synergistic effects
between the two domains of DLP-PH might have been observed
in that the entire peptide showed stronger activity against the
gram-negative bacteria tested than did either domain alone,
and notably the N-terminal domain, in isolation (Table 3). By
contrast, the N-terminal domain alone showed better activity
against the gram-positive S. aureus than did the complete
peptide.
Based on these results, we hypothesize that the amphiphilic α-
helical N-terminal domain is responsible for the actual bioactivity
of DLP-PH, probably by membrane lysis via pore formation.
However, the importance of the latter mechanism remains
uncertain to some degree, as it does for most amphibian
AMPs. Although our cytoplasmic leakage assays did indicate
cell lysis against all tested organisms, cell lysis for E. coli
was minimal at the empirically determined MIC (32µg/mL)
for this organism, implying some other mechanism for the
observed bioactivity (e.g., translocation of DLP-PH through the
non-lethal pores to instead target intracellular structures or
interfere with bacterial metabolism or growth cycles). Similarly,
the high leakage of cytoplasmic contents that was inferred
for C. albicans below its observed MIC (64µg/mL), indicates
that cell lysis alone appears to be insufficient for antimicrobial
action and that an additional, possibly intracellular, mechanism
is also required. Moreover, the antimicrobial potency of DLP-
PH was extremely decreased by the biofilm-forming sessile cells,
which indicates it failed to inhibit or eradicate microorganism
biofilm, whilst DLP-PH actually inhibited the initial attachment
of P. aeruginosa at a lower concentration than its MIC.
Apparently, such interaction is not able to induce either the
lethal of bacterial killing or inhibiting the biofilm formation,
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FIGURE 3 | (A) Effect of DLP-PH on cytoplasmic material release of S. aureus, E. coli, and C. albicans at 260 nm. The error bar represents the standard error for three
repeats (ANOVA, P < 0.05). (B) Effect of DLP-PH on the P. aeruginosa biofilm initial attachment. The error bar represents the standard error for three repeats. The
significance is given as *p < 0.05; **p < 0.01; ***p < 0.001. (C) Relative haemolysis of DLP-PH and its deviates on horse red blood cells. The 100% haemolysis was
defined using haemolytic effect induced by 1% Triton X-100 (ANOVA, P < 0.05).
FIGURE 4 | (A) The anti-proliferation effect and (B) cytotoxicity of DLP-PH on human cancer cell lines, H-157 and PC-3, and the normal human endothelial cell line,
HMEC-1 within the concentration range of 419.7 to 4.197 × 10−3 µg/mL. The error bar represents the standard error for three repeats. The significance is given as
*p < 0.05; **p < 0.01; ***p < 0.001.
we therefore assume that DLP-PH may further interfere the
attachment in a non-lethal mechanism, which was reported
that cationic AMPs may bind to bacteria cell or cover the
non-living surface to reduce bacterial adhesion (Segev-Zarko
et al., 2015). In addition, this effect is speculated to be mainly
related to the interaction of hydrophobicity instead of charge
(Phillips et al., 2007). It also indicates that this effect would be
only effective at the early stage of biofilm formation (within
1 h) due to the limited bacterial population, and it would be
eliminated by the reproduction of bacteria or generating more
hydrophobic compounds. Once the mature biofilm is formed,
the antimicrobial action of DLP-PH may be hampered by the
neutralization of extracellular polymeric substances (EPS) of
biofilm (Batoni et al., 2016).
By contrast, the highly cationic-charged C-terminal domain
would appear to be non-obligatory with respect to actual
bioactivity, but could facilitate the initial attachment of DLP-PH
onto the negatively charged bacterial cell membrane through
electrostatic attraction. As we known, the cell membrane of
most bacteria consists of more negatively-charged lipids, such as
cardiolipin and phosphatidylglycerol, than phosphatidylcholine,
and phosphatidylethanolamine that generally constitutes
mammalian cell membrane (Yeaman and Yount, 2003).
Evidence for the electrostatic attraction comes from molecular
docking model, which clearly showed that the cationic charged
residues, especially those in the C-terminal domain, mostly
TABLE 5 | Comparative study of the antimicrobial activities of DLP-PH, distinctin,
the B-chain of distinctin in isolation, Pexiganan and conventional antibiotic
ampicillin.
MIC
S. aureus E. coli P. aeruginosa
DLP-PHa 61.0 7.6 15.2
Distinctinb 23.4 11.7 23.4
Distinctin, B-chainb 43.3 24.7 43.3
Pexigananc 6.5 12.9 12.9
Ampicillina 0.06 45.8 >366.3
Unit: µM; ND: not determined.
aDetermined using the type strains mentioned in this study.
bMIC90 values at which 90% of the isolates tested were inhibited (Dalla Serra et al., 2008).
cDetermined using the same type strains mentioned in this study (Ge et al., 1999).
faced the negatively charged phospholipid head groups of the
bacteria model membrane, employing E. coli as a represent.
Additionally, the loss of function of DLP-PH in the divalent
cation supplemented medium indicates inhibition of the
electrostatic attraction to the microbial membrane through
competition from the additional cations. This proposed function
of the C-terminal domain might also explain why DLP-PH
was able to inhibit the growth of at least two human cancer
cells without showing other significant cytotoxic effects given
Frontiers in Microbiology | www.frontiersin.org 8 March 2018 | Volume 9 | Article 541
Wu et al. Antimicrobial Peptide With Low Cytotoxicity
that the cell membranes of cancer cells are known to be
more negatively charged than those of normal cells (Gaspar
et al., 2013). Again, it is unclear if anti-cancer activity results
solely primarily cellular membrane lysis (Papo and Shai, 2005)
and/or if interacting with cell surface receptors and influencing
intercellular signaling pathways (Scott et al., 2000) are also
involved. For example, gene microarray studies indicate that
some cationic peptides can regulate the expression of a number
of genes related to cell apoptosis and cell proliferation (Scott
et al., 2000).
Through its heterogeneous nature, DLP-PH structurally
somewhat resembles the AMP distinctin, which was isolated
from the congeneric frog Phyllomedusa distincta (Batista et al.,
2001). Distinctin itself is unusual in being a disulphide-
bridged, heterodimeric AMP. AMPs with disulphide bridges
are known and include human beta-defensins (HBDs) from
human leukocytes and epithelial cells (Schneider et al., 2005)
and cysteine-rich peptides (CRPs) from plants (Tam et al.,
2015), both of which adopt β-sheet structures that are stabilized
by two or more intramolecular disulphide bonds. They are
also present in the skin secretions of frogs, such as some
AMPs from Rana spp., which contain a disulphide-bridged
cyclic domain of varying size (six or seven residues; the “Rana
box” Conlon, 2011) and the Bowman-Birk inhibitor (BBI) like
peptides, which contain a canonical disulphide BBI loop with
11 residues (Song et al., 2008). However, in all these cases,
the disulphide bridge is intramolecular, whereas the bridge in
distinctin is found between the heterodimers, with each chain
being encoded by separate mRNAs (Evaristo et al., 2013) as
well as having distinct physiochemical properties, albeit not
as extreme as we found for the two domains of DLP-PH.
The resemblance between DLP-PH and distinctin is further
strengthened by the extremely high degree of similarity between
the primary structures of the N-terminal domain of DLP-PH
and the B-chain of distinctin. However, the exact relationship
between the two peptides remains unclear given the complete
lack of similarity between the remainder of DLP-PH and any part
of distinctin.
A functional similarity between DLP-PH and distinctin also
exists insofar as distinctin shows a broad-spectrum antimicrobial
activity against both gram-positive and gram-negative bacteria
and a generally doubled potency compared to the B-chain
in isolation (Table 5). In this, distinctin was more broad-
spectrum than DLP-PH, which showed less efficacy against
the gram-positive S. aureus; however, the antimicrobial activity
of DLP-PH against gram-negative bacteria was as good or
even better than distinctin or Pexiganan, an antibiotic in
late stage clinical trial that is derived from a frog skin
AMP. Notably, all AMPs or AMP-derived products were
much more effective against the gram-negative bacteria tested
than was the conventional antibiotic ampicillin. Considering
that DLP-PH is more potent against E. coli at the effective
concentration without damaging erythrocytes, it might benefit
the treatment for E. coli induced bacteremia. Additionally, most
AMPs process the amphipathic secondary structure, and such
structural characteristics have shown the ability of neutralizing
a board range of bacteria toxins (Kudryashova et al., 2017),
therefore, the further investigation on the inactivation of E. coli
toxins, like Shiga toxin, by DLP-PH might be interesting in
the drug discovery in the treatment of severe toxins-related
symptoms.
CONCLUSIONS
Given the novel structural and heterogenic physiochemical
properties of both DLP-PH and distinctin, it is worth
investigating both peptides in more detail as potential
antimicrobial and anticancer agents. Both peptides show
good bioactivity and, in the case of DLP-PH, minimal cytotoxic
effects against normal mammalian cells. One important
line of investigation would be to elucidate the potentially
different roles of the heterogenic domains of each peptide
toward the overall bioactivity. Such information could lead
to a greater understanding of the general mechanism(s) of
antimicrobial action of AMPs in general, thereby helping
to direct drug design (e.g., by modifying existing AMPs to
become better drug candidates). The anti-biofilm activity
of DLP-PH, although weaker than its general antimicrobial
activity, is also worthy of further study as a potential new
therapeutic direction in the fight against chronic diseases
caused by drug-resistant biofilms. Finally, the fact that we
discovered DLP-PH, which not only represents a novel
AMP, but might also be a prototype peptide of an entirely
new AMP family, in an otherwise well-studied frog species
argues for the continued investigation of the skin secretions
of amphibians to potentially provide many more new leads
for the therapeutic application for antibiotic design and
development.
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